20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. Pan, H.; Gray, R.; Braybrooke, J.; Davies, C.; Taylor, C.; McGale, P.; Peto, R.; Pritchard, K. I.; Bergh, J.; Dowsett, M.; Hayes, D. F.; Ebctcg. N Engl J Med. 2017; 1836-1846: p.1836-1846. doi:10.1056/NEJMoa1701830
Article